Arexvy Tag

GSK announces an expanded indication for Arexvy, and invites PAA members to register for their RSV Awareness Webinar Series, The Risk of Respiratory Syncytial Virus (RSV): Disease Burden and Vaccination. Log in to learn more and to register....

GSK has announced that the contract price for Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) will change effective 5/15/2025. Read details by logging in to the member site....